Bertis
BERTIS is a company specializing in proteomics-based precision medicine technology, focusing on early disease diagnosis and personalized treatment. They develop and commercialize advanced proteomics analysis solutions, including blood-based diagnostic tests for cancer detection and other health conditions. Their mission is to unravel the proteome for the next era of precision medicine, aiming to improve healthcare outcomes through innovative proteomics technologies.
Industries
Nr. of Employees
small (1-50)
Products
Proteomics-based blood test for early breast cancer detection
A blood-based diagnostic assay that quantifies multiple protein biomarkers and applies an algorithmic model to support early-stage breast cancer screening.
Proteomics data analysis platform
An integrated platform supporting protein data analysis, biomarker discovery, and downstream product and service development workflows.
Proteomics-based blood test for early breast cancer detection
A blood-based diagnostic assay that quantifies multiple protein biomarkers and applies an algorithmic model to support early-stage breast cancer screening.
Proteomics data analysis platform
An integrated platform supporting protein data analysis, biomarker discovery, and downstream product and service development workflows.
Services
Pan-omics analysis and bioinformatics service
Laboratory-based mass spectrometry proteomics combined with bioinformatics consulting to support research, drug discovery, and translational projects.
Clinical diagnostic testing service via laboratory partnerships
Provision and distribution of proteomics-based clinical testing through partner clinical laboratories and regional laboratory networks.
Pan-omics analysis and bioinformatics service
Laboratory-based mass spectrometry proteomics combined with bioinformatics consulting to support research, drug discovery, and translational projects.
Clinical diagnostic testing service via laboratory partnerships
Provision and distribution of proteomics-based clinical testing through partner clinical laboratories and regional laboratory networks.
Expertise Areas
- Proteomics-based diagnostics
- Pan-omics analysis and bioinformatics
- Biomarker discovery and validation
- Clinical diagnostic assay development
Key Technologies
- Mass spectrometry-based proteomics
- Pan-omics profiling
- Proteome and phosphoproteome analysis
- Bioinformatics pipelines for proteomics